NCT06819124 Examining Interactions Between PALS and Caregivers
| NCT ID | NCT06819124 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Penn State University |
| Condition | Amyotrophic Lateral Sclerosis (ALS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 152 participants |
| Start Date | 2025-01-22 |
| Primary Completion | 2029-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 152 participants in total. It began in 2025-01-22 with a primary completion date of 2029-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time? Participants will read words and sentences while they are interacting with their caregivers.
Eligibility Criteria
Inclusion Criteria: Speakers with amyotrophic lateral sclerosis (ALS) (PALS-people with ALS) * diagnosis of ALS following the revised EL Escorial criteria * no history of other neurological conditions (e.g., stroke) * no cognitive impairment assessed by Telephone Montreal Cognitive Assessment (mini MoCA) * detectable speech disturbance according to the ALS Functional Rating Scale-Revised (ALSFRS-R) * the ability to produce single words * being a native speaker of American English (AE). Caregivers * being a caregiver of a participant with ALS * being a native speaker of American English (AE). Exclusion Criteria: \- None - if volunteer meets the inclusion criteria, then they will be enrolled
Contact & Investigator
Jimin Lee, Ph.D.
PRINCIPAL INVESTIGATOR
Penn State University
Frequently Asked Questions
Who can join the NCT06819124 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Amyotrophic Lateral Sclerosis (ALS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06819124 currently recruiting?
Yes, NCT06819124 is actively recruiting participants. Contact the research team at ajo150@psu.edu for enrollment information.
Where is the NCT06819124 trial being conducted?
This trial is being conducted at University Park, United States.
Who is sponsoring the NCT06819124 clinical trial?
NCT06819124 is sponsored by Penn State University. The principal investigator is Jimin Lee, Ph.D. at Penn State University. The trial plans to enroll 152 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.